potassium chloride has been researched along with Neurodegenerative Diseases in 6 studies
Potassium Chloride: A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
potassium chloride : A metal chloride salt with a K(+) counterion.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current treatments for neurodegenerative diseases aim to alleviate the symptoms experienced by patients; however, these treatments do not cure the disease nor prevent further degeneration." | 1.62 | 3D Bioprinting Mesenchymal Stem Cell-Derived Neural Tissues Using a Fibrin-Based Bioink. ( Masri, NZ; Restan Perez, M; Sharma, R; Willerth, SM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Restan Perez, M | 1 |
| Sharma, R | 1 |
| Masri, NZ | 1 |
| Willerth, SM | 1 |
| Yin, LH | 1 |
| Shen, H | 1 |
| Diaz-Ruiz, O | 1 |
| Bäckman, CM | 1 |
| Bae, E | 1 |
| Yu, SJ | 1 |
| Wang, Y | 1 |
| Tamano, H | 1 |
| Takeda, A | 1 |
| Wood, PL | 1 |
| Khan, MA | 1 |
| Kulow, SR | 1 |
| Mahmood, SA | 1 |
| Moskal, JR | 1 |
| Kelicen, P | 1 |
| Cantuti-Castelvetri, I | 1 |
| Pekiner, C | 1 |
| Paulson, KE | 1 |
| O'Reilly, N | 1 |
| Xia, Z | 1 |
| Fiander, H | 1 |
| Tauskela, J | 1 |
| Small, DL | 1 |
6 other studies available for potassium chloride and Neurodegenerative Diseases
| Article | Year |
|---|---|
3D Bioprinting Mesenchymal Stem Cell-Derived Neural Tissues Using a Fibrin-Based Bioink.
Topics: Adipose Tissue; Bioprinting; Cell Survival; Cells, Cultured; Dopamine; Drug Design; Fibrin; Fibronec | 2021 |
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopaminer | 2012 |
Suppressive effect of Saiko-ka-ryukotsu-borei-to, a herbal medicine, on excessive release of glutamate in the hippocampus.
Topics: Animals; Body Weight; Disease Models, Animal; Drugs, Chinese Herbal; Excitatory Amino Acid Antagonis | 2004 |
Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines.
Topics: Aldehydes; Animals; Behavior, Animal; Cell Line; Cyclic N-Oxides; Disease Models, Animal; Dose-Respo | 2006 |
The spin trapping agent PBN stimulates H2 O2 -induced Erk and Src kinase activity in human neuroblastoma cells.
Topics: Calcium; Calcium Channels, L-Type; Central Nervous System; Cyclic N-Oxides; Drug Interactions; Epide | 2002 |
Disparity between ionic mediators of volume regulation and apoptosis in N1E 115 mouse neuroblastoma cells.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfo | 2002 |